Pershing Square (PS) president gets 10.1M M Units and holds 3.1M shares
Rhea-AI Filing Summary
Pershing Square Inc. president Hakim Ben reported multiple equity transactions involving the company’s common stock and related partnership units. On April 30, 2026, he received 75,000 shares of common stock as a grant and recorded an additional 20,000-share adjustment classified as another acquisition or disposition.
On the same date, he disposed of 231,388 common shares back to the issuer, and after these transactions he directly held 3,134,632 common shares. Separately, on April 28, 2026, he was granted 10,098,060 M Units of Pershing Square Partner Group, LLC, initially tied to 9,403,895 underlying common shares.
The M Units were granted on a pro rata basis to his prior interest in the partnership, are unvested, and follow a long-term vesting schedule over up to ten years. Once vested, each M Unit may be redeemed, subject to conditions and adjustments, for one share of Pershing Square common stock held by the partnership, with redemption rights that do not expire.
Positive
- None.
Negative
- None.
Insights
Large equity grant and internal adjustments create long-dated exposure, but no open-market buying or selling.
Pershing Square Inc. president Hakim Ben reported equity awards and internal capital structure adjustments rather than open-market trades. He received 75,000 common shares and a sizeable grant of 10,098,060 M Units, initially linked to 9,403,895 underlying common shares.
The filing also shows a disposition of 231,388 common shares back to the issuer and an additional 20,000-share adjustment categorized as an “other” transaction. These events are tied to a combined IPO and private placement structure and a purchase price adjustment mechanism involving Pershing Square Partner Group, LLC.
The M Units vest gradually over up to 10 years with stepped percentages and can be redeemed one-for-one for issuer common stock held by the partnership, with no expiration on redemption rights. The overall pattern points to long-term, performance-linked equity alignment rather than short-term trading activity.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Common Stock | 231,388 | $0.00 | -- |
| Other | Common Stock | 20,000 | $0.00 | -- |
| Grant/Award | Common Stock | 75,000 | $0.00 | -- |
| Grant/Award | M Units of Pershing Square Partner Group, LLC | 10,098,060 | $0.00 | -- |
Footnotes (1)
- On April 30, 2026, the Issuer and Pershing Square USA, Ltd. ("PSUS") completed a combined transaction, consisting of (i) an initial public offering (the "PS IPO") and a concurrent private placement (the "PS Private Placement") of Issuer common stock and (ii) an initial public offering (the "PSUS IPO" and together with the PS IPO, the "combined IPO") and a concurrent private placement (the "PSUS Private Placement" and together with the PS Private Placement, the "combined private placement") of PSUS's Common Shares of Beneficial Interest ("PSUS Common Shares") (collectively, the "combined transaction"). Pursuant to the Amended and Restated Purchase Price Adjustment Agreement (the "A&R Purchase Price Adjustment Agreement") by and among the Issuer, Pershing Square Partner Group, LLC ("PSPG") and the other parties thereto (including the Reporting Person), PSPG and other parties thereto (including the Reporting Person) contributed Issuer common stock to the Issuer in an aggregate amount equal to the number of shares of Issuer common stock issued in connection with the combined transaction. Each party's contribution ("Purchase Price Adjustment Contribution") corresponds to such party's pro rata share of the aggregate number of shares of Issuer common stock held by the parties as of immediately prior to the completion of the combined transaction. Reflects the acquisition of Issuer common stock in connection with the combined IPO. In connection with the PS IPO, each initial investor acquired 1 share of Issuer common stock for no additional consideration for every 5 PSUS Common Shares that the investor purchased in the PSUS IPO. Reflects the acquisition of Issuer common stock in connection with the combined private placement. In connection with the PS Private Placement, each initial investor acquired 1.5 shares of Issuer common stock for no additional consideration for every 5 PSUS Common Shares that the investor purchased in the PSUS Private Placement. These M Units ("M Units") of PSPG were granted to the Reporting Person pursuant to an amendment of PSPG's governing document on a pro rata basis of the Reporting Person's prior interest in PSPG on April 28, 2026. The M Units are unvested and subject to vesting and forfeiture. The standard vesting schedule for M Units provides for vesting (i) 6.25% each year during years 1 to 4, (ii) 8.33% each year during years 5 to 7, and (iii) 16.67% each year during years 8 to 10. The grant was approved by the board of directors of the Issuer in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, as amended. Upon vesting, each M Unit may be redeemed by the holder, subject to certain conditions, for shares of Issuer common stock held by PSPG on a one-for-one basis, subject to certain adjustments pursuant to the terms approved by the board of directors of the Issuer. These redemption rights do not expire. Reflects the pro rata adjustment, pursuant to PSPG's governing document in connection with its Purchase Price Adjustment Contribution, of the number of shares of Issuer common stock for which each M unit may be redeemed.